- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.09. | Glenmark, South Piedmont Launch Pharma Training Facility | 4 | Contract Pharma | ||
| 26.08. | Glenmark Pharmaceuticals Ltd soars 1.8%, rises for third straight session | 2 | capitalmarket.com | ||
| GLENMARK PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 21.08. | Glenmark Pharma's US arm launches Calcium Gluconate injection in various formats | 2 | capitalmarket.com | ||
| 21.08. | Glenmark Pharmaceuticals among 5 stocks showing bullish RSI upswing | 2 | Times of India | ||
| 20.08. | Glenmark Pharma gets USFDA nod for Fluticasone Propionate Nasal Spray | 4 | capitalmarket.com | ||
| 03.08. | Glenmark Q1 FY27 slides: 23% revenue growth, innovation pipeline expands | 3 | Investing.com | ||
| 15.07. | Glenmark Pharmaceuticals Ltd soars 0.08%, up for fifth straight session | 3 | capitalmarket.com | ||
| 06.07. | Glenmark Pharmaceuticals Ltd up for third consecutive session | 2 | capitalmarket.com | ||
| 06.07. | Glenmark Pharma gains as US arm launches generic Olanzapine injection | 2 | capitalmarket.com | ||
| 17.06. | Glenmark Pharma arm launches generic Methylene Blue Injection in US market | 3 | capitalmarket.com | ||
| 11.06. | Glenmark Pharmaceuticals launches Winlevi across key European markets | 2 | capitalmarket.com | ||
| 11.06. | Cosmo Pharmaceuticals N.V.: Cosmo Welcomes the Launch of Winlevi(R) in Key European Markets by Its Partner Glenmark | 854 | Newsfile | Dublin, Ireland--(Newsfile Corp. - June 11, 2026) - Cosmo N.V. (SIX: COPN) (XETRA: C43) ("Cosmo") is pleased to make known that its commercial partner Glenmark Specialty S.A (GSSA), a wholly-owned... ► Artikel lesen | |
| 10.06. | Stock Alert: KRN Heat, Patanjali Foods, Bharti Airtel, Dixon Tech, Glenmark Pharma, Bharti Hexacom | 3 | capitalmarket.com | ||
| 05.06. | Glenmark Pharma launches generic Lacosamide injection in US | 2 | capitalmarket.com | ||
| 02.06. | Klage gegen Glenmark: Lieferengpässe: Kein Schadenersatz für DAK | 4 | APOTHEKE ADHOC | ||
| 01.06. | Stocks to Watch Today (June 01, 2026): IndiGo, Glenmark Pharma, IREDA, NMDC, Jubilant Pharmova, Cyient and more | 2 | ZEE Business | ||
| 01.06. | Stock Alert: RPP Infra Projects, Indigo, NMDC, GRM Overseas, Glenmark Pharma, NOCIL | 2 | capitalmarket.com | ||
| 30.05. | Glenmark Pharma posts robust Q4 performance | 3 | capitalmarket.com | ||
| 20.05. | IGI, Inc.: Ichnos Glenmark Innovation (IGI) Announces New Development Candidate, ISB 2301, a First-in-Class Multispecific Immune Cells Activator Targeting Solid Tumors | 651 | GlobeNewswire (Europe) | Next-generation multispecific antibody, ISB 2301, targets 3 tumor-associated antigens (TAAs) and activates both T cells and natural killer (NK) cells
IGI's clinically validated BEAT platform enabled... ► Artikel lesen | |
| 18.05. | Glenmark Launches Vancomycin Injection In US, Targets Rs 37.9 Million Market | 2 | The Free Press Journal |
1 2 Weiter >>
31 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SINOPHARM | 1,655 | +1,04 % | SINOPHARM (01099): ANNOUNCEMENT (1) POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON TUESDAY, 15 SEPTEMBER 2026; AND (2) ELECTION OF CHAIRMAN ... | ||
| CSPC PHARMA | 1,006 | +1,99 % | CSPC PHARMA (01093): NOTIFICATION LETTER TO NON-REGISTERED HOLDER AND REQUEST FORM | ||
| WUXI BIOLOGICS | 5,580 | -0,18 % | WUXI BIO (02269): NEXT DAY DISCLOSURE RETURN | ||
| SHANGHAI FOSUN PHARMACEUTICAL | 1,872 | -2,98 % | FOSUN PHARMA Repurchases 1.3 Million Shares on Sep 18 Involving Approx. HKD22.77 Million | ||
| GEDEON RICHTER | 35,100 | -1,07 % | Gedeon Richter: Das "House of Hope" in Bamako leistet auch 2026 weiterhin lebenswichtige Hilfe für schutzbedürftige Frauen in Mali | BUDAPEST, UNGARN / ACCESS Newswire / 22. Juli 2026 / Das "Gedeon Richter House of Hope"-Zentrum in
Bamako, Mali, leistete auch in der ersten Hälfte des Jahres... ► Artikel lesen | |
| DR REDDYS | 10,500 | +5,00 % | DR REDDYS LABORATORIES LTD - 6-K, Report of foreign issuer | ||
| ASPEN PHARMACARE | 8,400 | +1,20 % | Earnings Call: Aspen Pharmacare hebt Gewinnprognose für GJ 2026 an und stellt starkes Wachstum für 2027 in Aussicht | ||
| SHANGHAI PHARMACEUTICALS | 1,160 | -0,85 % | SH PHARMA (02607): INTERIM REPORT 2026 | ||
| LUYE PHARMA | 0,192 | +2,67 % | LUYE PHARMA (02186): VOLUNTARY ANNOUNCEMENT MRNA VACCINE LY01620 FOR THE TREATMENT OF CERVICAL PRECANCEROUS LESIONS AND HPV-RELATED TUMORS TO ENTER INTO ... | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,079 | +0,64 % | SIHUAN PHARM (00460): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDER | ||
| HANSOH PHARMACEUTICAL | 3,869 | +1,58 % | HANSOH PHARMA Receives NMPA Approval for Clinical Trial | ||
| CHINA RESOURCES PHARMACEUTICAL | 0,500 | +2,46 % | CHINARES PHARMA Subsidiary Forges Strategic Co-op With SBP GROUP | ||
| CHINA SHINEWAY PHARMACEUTICAL GROUP | 0,915 | +0,55 % | SHINEWAY PHARM (02877): SPECIAL INTERIM DIVIDEND IN RESPECT OF THE FISCAL YEAR 2026 | ||
| KALBE FARMA | 0,040 | 0,00 % | KLBF set to conduct IDR 500 billion share buyback: The company plans to use internal funds to finance the share ... | ||
| BAYER | 48,090 | -1,94 % | Platzt der Knoten?: Bayer-Aktie vor dem wichtigsten Glyphosat-Termin der Unternehmensgeschichte? | © Foto: KI-generiert mit DALL-EVor fast 10 Jahren hat Bayer Monsanto übernommen. Damals hat wohl niemand in Leverkusen damit gerechnet, dass eine jahrelange Prozessflut damit verbunden ist. Biegt die... ► Artikel lesen |
GLENMARK PHARMACEUTICALS LTD gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLENMARK PHARMACEUTICALS LTD finden Sie auf Wallstreet Online.